Automate Your Wheel Strategy on LH
With Tiblio's Option Bot, you can configure your own wheel strategy including LH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol LH
- Rev/Share 161.4826
- Book/Share 101.6695
- PB 2.7557
- Debt/Equity 0.7726
- CurrentRatio 1.5044
- ROIC 0.0583
- MktCap 23236422000.0
- FreeCF/Share 15.1114
- PFCF 18.4153
- PE 30.5846
- Debt/Assets 0.3625
- DivYield 0.0103
- ROE 0.0925
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | LH | HSBC Securities | Buy | Hold | -- | $260 | July 10, 2025 |
| Initiation | LH | Redburn Atlantic | -- | Buy | -- | $276 | April 2, 2025 |
| Upgrade | LH | Citigroup | Neutral | Buy | $250 | $300 | March 4, 2025 |
| Upgrade | LH | Evercore ISI | In-line | Outperform | $260 | $265 | Jan. 7, 2025 |
| Resumed | LH | Jefferies | -- | Buy | $265 | $275 | Dec. 10, 2024 |
| Initiation | LH | Piper Sandler | -- | Neutral | -- | $235 | Oct. 1, 2024 |
News
Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities
Published: September 30, 2025 by: PRNewsWire
Sentiment: Neutral
Labcorp to leverage Roche's digital pathology technology to expand access, enhance efficiency and support AI integration across anatomic pathology services BURLINGTON, N.C. , Sept. 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today a collaboration with Roche to implement the company's FDA-cleared VENTANA® DP 600 and DP 200 slide scanners.
Read More
Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?
Published: September 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
Reasons to Add Labcorp Stock to Your Portfolio Right Now
Published: September 23, 2025 by: Zacks Investment Research
Sentiment: Positive
LH's biopharma lab growth and efficiency gains boost momentum, but currency and macro pressures weigh on its outlook.
Read More
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
LH Stock Rises on Acquisition of BioReference Health's Select Assets
Published: September 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Labcorp's $225M acquisition of BioReference Health select assets boosts its oncology diagnostics portfolio and expands patient access nationwide.
Read More
Here's Why Labcorp Holdings (LH) is a Strong Growth Stock
Published: September 16, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Labcorp Holdings Inc. (LH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Published: September 09, 2025 by: Seeking Alpha
Sentiment: Neutral
Labcorp Holdings Inc. (NYSE:LH ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 7:45 AM EDT Company Participants Adam Schechter - President, CEO & Chairman Julia Wang - CFO & Executive VP Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Presentation Erin Wilson Wright Equity Analyst Good morning, everyone. I'm Erin Wright, health care services analyst at Morgan Stanley.
Read More
Is it the Right Time to Hold Labcorp Stock in Your Portfolio?
Published: August 26, 2025 by: Zacks Investment Research
Sentiment: Negative
LH witnesses growth in specialty testing and strategic acquisitions, but macro and currency headwinds remain a concern.
Read More
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Why Labcorp Holdings (LH) is a Top Growth Stock for the Long-Term
Published: August 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up
Published: August 19, 2025 by: Zacks Investment Research
Sentiment: Positive
LH launches the first FDA-cleared blood test for Alzheimer's, boosting access to early diagnosis and nudging its stock higher.
Read More
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease
Published: August 18, 2025 by: PRNewsWire
Sentiment: Neutral
Lumipulse® pTau-217/Beta Amyloid 42 Ratio now available nationwide through Labcorp BURLINGTON, N.C. , Aug. 18, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the availability of the Lumipulse® pTau-217/Beta Amyloid 42 Ratio, the first blood-based in-vitro diagnostic (IVD) test cleared by the U.S. Food and Drug Administration (FDA) to aid in the diagnosis of Alzheimer's disease through early detection of the amyloid plaques associated with the disease in appropriate patients.
Read More
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
Published: August 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search
Published: July 30, 2025 by: PRNewsWire
Sentiment: Neutral
Test Finder interprets provider questions in context to deliver curated, clinically relevant results, going beyond traditional search Developed in collaboration with Amazon Web Services, Test Finder is now available on Labcorp.com BURLINGTON, N.C. , July 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Test Finder, a first-of-its-kind generative AI tool developed with Amazon Web Services (AWS).
Read More
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
Published: July 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript
Published: July 24, 2025 by: Seeking Alpha
Sentiment: Neutral
Labcorp Holdings Inc. (NYSE:LH ) Q2 2025 Earnings Conference Call July 24, 2025 9:00 AM ET Company Participants Adam H. Schechter - President, CEO & Chairman Christin O'Donnell - Vice President of Investor Relations Julia A.
Read More
Labcorp (LH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: July 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Labcorp Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
Published: July 24, 2025 by: Zacks Investment Research
Sentiment: Positive
LH tops Q2 estimates with double-digit EPS growth, margin gains and a raised 2025 outlook, lifting shares pre-market.
Read More
What Analyst Projections for Key Metrics Reveal About Labcorp (LH) Q2 Earnings
Published: July 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Labcorp (LH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
Read More
Labcorp Q2 Earnings Preview: Diagnostics Strength in Focus
Published: July 21, 2025 by: Zacks Investment Research
Sentiment: Positive
LH is likely to report Q2 growth with diagnostics momentum, key acquisitions, and new biomarker tests bolstering revenue gains.
Read More
Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report?
Published: July 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Labcorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Labcorp Holdings (LH) Earnings Expected to Grow: Should You Buy?
Published: July 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Labcorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
What Makes Labcorp (LH) a New Buy Stock
Published: July 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Labcorp (LH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read More
Labcorp Stock Climbs 25.6% This Year: What's Driving the Surge?
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Positive
LH stock surges 25.6% this year, powered by specialty testing expansion, key acquisitions and solid financials.
Read More
Should You Continue to Hold Labcorp Stock in Your Portfolio?
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Labcorp Holdings Inc. LH, or Labcorp's strong focus on key areas such as oncology, women's health, autoimmune disease and neurology is poised to help it grow in the upcoming quarters. The company maintains a steady pipeline of potential deals that support its financial strategy and will enhance its organic growth.
Read More
LH Stock Rises Following the Expansion of Precision Oncology Portfolio
Published: June 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Labcorp expands its precision oncology lineup with new cancer tests and a global diagnostic tool.
Read More
ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage
Published: June 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, June 02, 2025 (GLOBE NEWSWIRE) -- InStride , a leading provider of strategic education and skilling solutions, has facilitated a unique partnership between Arizona State University's College of Health Solutions and Labcorp, a global leader of innovative and comprehensive laboratory services, to launch a Master of Science in Cytology. ASU's online graduate program addresses the severe shortage of cytotechnologists—specialists essential to cancer detection and diagnostics.
Read More
Why Is Labcorp (LH) Up 2.5% Since Last Earnings Report?
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Labcorp (LH) reported earnings 30 days ago. What's next for the stock?
Read More
LH or SAUHY: Which Is the Better Value Stock Right Now?
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Labcorp (LH) or Straumann Holding AG (SAUHY). But which of these two stocks presents investors with the better value opportunity right now?
Read More
About Labcorp Holdings Inc. (LH)
- IPO Date 1990-03-29
- Website https://www.labcorp.com
- Industry Medical - Equipment & Services
- CEO Adam H. Schechter
- Employees 60900